血液科
使用血漿替代物進行治療性血漿置換
Starch and albumin mixture as replacement fluid in therapeutic plasma exchange is safe and effective. (開啟新視窗)
來源: J Clin Apher 2008;23(5):163-7.
檢索: PubMed 18819155
DOI碼: 10.1002/jca.20175
Hydroxyethylstarch as a replacement fluid in therapeutic plasma exchange for lupus nephritis in a Jehovah's Witness. (開啟新視窗)
來源: Transfus Apher Sci 2003;28(1):101-2.
檢索: PubMed 12620275
DOI碼: 10.1016/S1473-0502(02)00105-2
Treatment of thrombotic thrombocytopenic purpura with the cryosupernatant fraction of plasma: a case report and review of the literature. (開啟新視窗)
來源: Am J Med Sci 1999;318(3):190-3.
檢索: PubMed 10487410
Pentastarch as partial replacement fluid for therapeutic plasma exchange: effect on plasma proteins, adverse events during treatment, and serum ionized calcium. (開啟新視窗)
來源: J Clin Apher 1999;14(3):114-21.
檢索: PubMed 10540365
Immunoadsorption in Guillain-Barré syndrome and myasthenia gravis. (開啟新視窗)
來源: Ther Apher 2000;4(3):195-7.
檢索: PubMed 10910018
Replacement fluids in plasmapheresis: cross-over comparative study. (開啟新視窗)
來源: Intensive Care Med 1997;23(3):342-4.
檢索: PubMed 9083239
Tryptophan-immobilized column-based immunoadsorption as the choice method for plasmapheresis in Guillain-Barré syndrome. (開啟新視窗)
來源: Ther Apher Dial 2004;8(3):248-53.
檢索: PubMed 15154879
DOI碼: 10.1111/j.1526-0968.2004.00138.x
Pentastarch instead of albumin as replacement fluid for therapeutic plasma exchange. The Canadian Apheresis Group. (開啟新視窗)
來源: J Clin Apher 1997;12(4):165-9.
檢索: PubMed 9483177